Esco Aster is a specialized biomanufacturing platform with a proven track record of working with startups, well-funded biotechs, medical and healthcare centers to help them achieve critical fundraising and investment milestones.
Esco Aster provides consultancy and fractional talent services to support life sciences and biotechs as they progress from innovation to commercialization and scale. Drawing on deep technical, operational, and investment experience, we work closely with clients to navigate complex strategic, financial, and execution challenges across different stages of growth.
Our consultancy and fractional talent services span both the buy-side and sell-side, supporting stakeholders across the entire ecosystem—from academia and research institutions to governments, corporates, and capital providers.
We are adept at working with organizations of different sizes and stages, including small- to medium-sized enterprises seeking to commercialize intellectual property or identify new engines for business growth, as well as large local enterprises, multinational corporations, and conglomerates pursuing mergers and acquisitions, including through their corporate venture capital arms.
Our model is designed to be flexible and impact-driven. Rather than offering purely advisory input, Esco Aster integrates strategic thinking with hands-on execution, acting as an extension of our clients’ teams to deliver practical outcomes aligned with long-term value creation.
Esco Aster supports companies from the earliest stages—often even prior to spin-out—by helping assess market fit and validate whether there is a genuine unmet need that justifies further development, investment, or the creation of a new venture.
This early-stage engagement focuses on reducing uncertainty and risk. By assessing market dynamics, competitive landscapes, and commercialization pathways, we help clients make informed decisions about how and when to proceed, resulting in a clearer strategic direction and a stronger foundation for growth.
As companies progress toward fundraising or strategic partnerships, we provide hands-on support in building investor-ready materials and positioning. Our work includes pitch decks, marketing and communications assets, data rooms, techno-economic analysis models, and robust business and financial models.
In addition, Esco Aster connects clients to strategic capital through our value-added fundraising-as-a-service offering (hyperlink), helping align investors with long-term objectives rather than short-term funding needs.
Our experience enables us to bridge the gap between science, industry, and investment. For smaller and mid-sized organizations, this may involve commercializing intellectual property or developing new engines for business growth. For larger enterprises and conglomerates, including those with corporate venture capital arms, our support often focuses on strategic investments, partnerships, mergers, and acquisitions.
This ecosystem-wide perspective allows us to align diverse interests and guide complex transactions with clarity and confidence.
Beyond strategy and capital, Esco Aster offers fractional talent and operational support to help organizations execute and scale efficiently. Through this model, clients gain access to experienced professionals and institutional-grade capabilities—without the overhead of building full in-house teams from the outset.
Our services extend to outsourced accounting and corporate secretarial functions, financial planning and modeling, and the implementation of full enterprise resource planning (ERP) systems using Business Central 365 (BC365).
By integrating operational discipline with strategic oversight, Esco Aster helps organizations establish strong, scalable foundations that support sustainable growth, operational excellence, and long-term value creation.